Update manual on borderline classification IVDR and MDR published

    Update manual on borderline classification IVDR and MDR published

    Regulatory Affairs Medical Devices In Vitro Diagnostics EU MDR EU IVDR

    Tuesday, 30 September 2025

    person-image

    Kirsten Van Garsse, Authorized Representative Director & Regulatory Affairs Manager IVD

    share-iconshare-icon-mob Share

    X (Twitter) icon\ \ X (Twitter) LinkedIn icon\ \ LinkedIn WhatsApp icon\ \ WhatsApp Copy link icon\ \ Copy link Mail icon\ \ Mail

    On 12 September 2025 a new manual on borderline classification IVDR and MDR was published

    Play

    Update manual on borderline classification IVDR and MDR | QbD Group

    AI-generated audio

    0:42

    The revision includes clarifications for borderline cases, including red blood cell additive solutions containing adenine, dual action creams with menthol and capsaicin, lactose tablets for vaginal use, microabrasion dental stain removers, medical examination table covers, and mobile sterile air systems. Other examples remain unchanged.

    What does this mean for you?

    Manufacturers and regulatory teams can use the updated manual to confirm the correct qualification and classification of their products, supporting compliance decisions and avoiding potential regulatory disputes.

    CTA RA update MD

    CTA RA update MD

    Get in touch with our experts

    Should you want to discuss this more in-depth with one of our consultants, please do not hesitate to contact us.

    Contact us

    Discover more expert content

    Previous

    Regulatory Affairs

    30 Apr 2024

    EU Parliament Passes Groundbreaking Proposal

    On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...

    Read more

    Regulatory Affairs

    6 Feb 2025

    PMS Statutory Instrument + MHRA Guidance released (Great Britain)

    The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...

    Read more

    Regulatory Affairs

    30 Sep 2025

    New MDCG position paper released on the timelines of implementation of Master UDI-DI to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles

    The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations,...

    Read more

    Regulatory Affairs

    23 Jan 2024

    Comprehensive Overview of Language Requirements under IVDR/MDR for Medical Device Manufacturers

    EU Commission published MDR and IVDR language requirement tables for medical device manufacturers,...

    Read more

    Regulatory Affairs

    23 Feb 2024

    Proposed Amendments to IVDR and MDR: Transitional Provisions, EUDAMED Roll-Out, and Supply Chain Interruptions

    EU Commission proposes IVDR & MDR amendments: Eudamed rollout, supply interruption reporting,...

    Read more

    Regulatory Affairs

    30 Apr 2024

    EU Parliament Passes Groundbreaking Proposal

    On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...

    Read more

    Regulatory Affairs

    6 Feb 2025

    PMS Statutory Instrument + MHRA Guidance released (Great Britain)

    The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...

    Read more

    Regulatory Affairs

    30 Sep 2025

    New MDCG position paper released on the timelines of implementation of Master UDI-DI to contact lenses and spectacle frames, spectacle lenses and ready-to-wear reading spectacles

    The paper explains how the Master UDI-DI solution, introduced through recent Delegated Regulations,...

    Read more

    Regulatory Affairs

    23 Jan 2024

    Comprehensive Overview of Language Requirements under IVDR/MDR for Medical Device Manufacturers

    EU Commission published MDR and IVDR language requirement tables for medical device manufacturers,...

    Read more

    Regulatory Affairs

    23 Feb 2024

    Proposed Amendments to IVDR and MDR: Transitional Provisions, EUDAMED Roll-Out, and Supply Chain Interruptions

    EU Commission proposes IVDR & MDR amendments: Eudamed rollout, supply interruption reporting,...

    Read more

    Regulatory Affairs

    30 Apr 2024

    EU Parliament Passes Groundbreaking Proposal

    On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...

    Read more

    Regulatory Affairs

    6 Feb 2025

    PMS Statutory Instrument + MHRA Guidance released (Great Britain)

    The Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance to assist...

    Read more

    Next

    • 1
    • 2
    • 3

    Discover all

    Stay ahead in life sciences

    Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

    Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

    Subscribe to our newsletter

    Circles-banner-short

    Twitter Widget Iframe